Assessing glycemic control in patients with diabetes and end-stage renal failure - PubMed (original) (raw)

Review

Assessing glycemic control in patients with diabetes and end-stage renal failure

Adeel Ansari et al. Am J Kidney Dis. 2003 Mar.

Abstract

Blood glucose monitoring is important in optimizing long-term outcomes in diabetic patients. Reliance on near-patient testing and the use of longer term measures of glycation are the current cornerstones. However, as this review details, there are significant problems using blood tests as measures of metabolic control in uremic diabetic patients.

Copyright 2003 by the National Kidney Foundation, Inc.

PubMed Disclaimer

Similar articles

• [Problems of metabolic control in type I diabetic patients with chronic renal failure].
  Zander VE, Schulz B, Conde N, Templin R. Zander VE, et al. Z Urol Nephrol. 1988 Mar;81(3):179-85. Z Urol Nephrol. 1988. PMID: 3291484 German.
• A quality improvement model for optimizing care of the diabetic end-stage renal disease patient.
  Mahnensmith RL, Zorzanello M, Hsu YH, Williams ME. Mahnensmith RL, et al. Semin Dial. 2010 Mar-Apr;23(2):206-13. doi: 10.1111/j.1525-139X.2010.00717.x. Semin Dial. 2010. PMID: 20525109
• Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?
  Finkelstein FO, Smith JD. Finkelstein FO, et al. ASAIO J. 1996 Jan-Feb;42(1):1-3. ASAIO J. 1996. PMID: 8808447 Review. No abstract available.
• Management of diabetes in patients with chronic kidney disease.
  Ahmed Z, Simon B, Choudhury D. Ahmed Z, et al. Postgrad Med. 2009 May;121(3):52-60. doi: 10.3810/pgm.2009.05.2002. Postgrad Med. 2009. PMID: 19491540 Review.

Cited by

• Factors Associated With Discordant A1C-Estimated and Measured Average Glucose Among Hospitalized Patients With Diabetes.
  Wallam S, Abusamaan MS, Clarke W, Mathioudakis N. Wallam S, et al. Clin Diabetes. 2023 Spring;41(2):208-219. doi: 10.2337/cd22-0047. Epub 2022 Sep 27. Clin Diabetes. 2023. PMID: 37092143 Free PMC article.
• Efficacy and safety of Keluoxin capsule in combination with Western medicine for diabetic kidney disease: A systematic review and meta-analysis.
  Zhang W, Zhou J, Wang C, Wang X, Zhang S, Jia W, Jiang Y, Lin L, Gong Y. Zhang W, et al. Front Pharmacol. 2023 Jan 4;13:1052852. doi: 10.3389/fphar.2022.1052852. eCollection 2022. Front Pharmacol. 2023. PMID: 36686708 Free PMC article.
• Assessment of glycemia in chronic kidney disease.
  Hassanein M, Shafi T. Hassanein M, et al. BMC Med. 2022 Apr 13;20(1):117. doi: 10.1186/s12916-022-02316-1. BMC Med. 2022. PMID: 35414081 Free PMC article. Review.
• Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis.
  Iyengar R, Franzese J, Gianchandani R. Iyengar R, et al. Curr Diab Rep. 2018 Aug 15;18(10):75. doi: 10.1007/s11892-018-1044-y. Curr Diab Rep. 2018. PMID: 30112652 Review.
• Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease.
  Kuo IC, Lin HY, Niu SW, Lee JJ, Chiu YW, Hung CC, Hwang SJ, Chen HC. Kuo IC, et al. PLoS One. 2018 Jun 22;13(6):e0199378. doi: 10.1371/journal.pone.0199378. eCollection 2018. PLoS One. 2018. PMID: 29933406 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information